Low-dose IL-2 treatment rescues cognitive deficits by repairing the imbalance between Treg and Th17 cells at the middle Alzheimer's disease stage

Medicine, Rheumatology and Immunology, Neurology, Life Sciences, Immunology,
low-dose IL-2 treatment   Alzheimer's disease   cognitive deficits   Treg   Th17   immune imbalance  

Low-dose IL-2 treatment rescues cognitive deficits by repairing the imbalance between Treg and Th17 cells at the middle Alzheimer’s disease stage Background Alzheimer’s disease (AD) is an age-related neurodegenerative disorder characterized by neuronal damage, amyloid plaque deposition, and chronic inflammation in the central nervous system (CNS). ...